Samir Rashmikant Patel

Sits on 1 board. Last updated September 28, 2026

Time on boards

Boards served
1
Current seats
1
Board service
3 years
Director since
2024

3 years of board service in total across 1 board, counting each seat separately. Longest: Akari Therapeutics plc, 2 years.

2 years · Since 2024

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Date Company Transaction Shares Price Value
Oct 5, 2026 Akari Therapeutics plc Grant or award +2,236 $7.90 $17,662
Aug 18, 2026 Akari Therapeutics plc Grant or award +6,300 $7.90 $49,764
Jul 7, 2026 Akari Therapeutics plc Option exercise +1,209 $8.00 $9,672
Jul 7, 2026 Akari Therapeutics plc Option exercise +15,466 — —
Jul 7, 2026 Akari Therapeutics plc Option exercise +5,799 — —
Mar 6, 2025 Akari Therapeutics plc Grant or award +406,250 $1.12 $455,000
Jan 3, 2025 Akari Therapeutics plc Grant or award +208,000 — —
Dec 27, 2024 Akari Therapeutics plc Grant or award +400,000 — —
Dec 26, 2024 Akari Therapeutics plc Grant or award +3,200,000 — —
Dec 24, 2024 Akari Therapeutics plc Grant or award +7,500,000 — —
Dec 23, 2024 Akari Therapeutics plc Grant or award +1,400,000 — —
Dec 20, 2024 Akari Therapeutics plc Grant or award +1,400,000 — —
Dec 2, 2024 Akari Therapeutics plc Grant or award +419,286,000 — —
Nov 14, 2024 Akari Therapeutics plc Grant or award +1,404,622,000 — —
Jun 30, 2024 Akari Therapeutics plc Grant or award +91,396,000 — —

Questions about Samir Rashmikant Patel

What boards is Samir Rashmikant Patel on?

Samir Rashmikant Patel sits on the board of Akari Therapeutics plc.

How long has Samir Rashmikant Patel served on boards?

Our records show at least 3 years of board service across 1 board, the earliest from 2024.

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.